Abstract:α-Mannoside β-1,6-<i>N</i>-acetylglucosaminyltransferase V (MGAT5) is a mammalian glycosyltransferase involved in complex N-glycan formation, which strongly drives cancer when overexpressed. Despite intense interest, the catalytic mechanism of MGAT5 is not known in detail, precluding therapeutic exploitation. We solved structures of MGAT5 complexed to glycosyl donor and acceptor ligands, revealing an unforeseen role for donor-induced loop rearrangements in controlling acceptor substrate engagement. QM/MM metadynamics simulations of MGAT5 catalysis highlight the key assisting role of Glu297 and reveal considerable conformational distortions imposed upon the glycosyl donor during transfer. Detailed mechanistic characterization of MGAT5 will aid inhibitor development to correct cancer-associated N-glycosylation.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acscatal.0c02222?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acscatal.0c02222</a>.Michaelis–Menten kinetics graphs, MGAT5 ribbon and surface representations, root-mean-square deviations between different MGAT5 crystal forms, STARANISO<sup>2</sup> calculated plots of reciprocal lattice points, comparison of M592 complex with previously reported MGAT5 acceptor complex, UDP-2FGlc ternary complex, MGAT5 acceptor subsite surfaces, analysis of protein atom root mean square displacements during the MD simulation timecourse, distribution of Michaelis complex C1–O6 distances during the MD simulation, data collection and refinement statistics, PDB accession codes, cloning primers, methods, and supporting references (<a class="ext-link" href="/doi/suppl/10.1021/acscatal.0c02222/suppl_file/cs0c02222_si_001.pdf">PDF</a>)Video of the MGAT5 catalytic mechanism (<a class="ext-link" href="/doi/suppl/10.1021/acscatal.0c02222/suppl_file/cs0c02222_si_002.mp4">MP4</a>)This article has not yet been cited by other publications.

A Bioorthogonal Precision Tool for human N-acetylglucosaminyltransferase V

Spatiotemporal Activation of Protein O-GlcNAcylation in Living Cells.

Characterization of a Bacterial Beta-1,3-galactosyltransferase with Application in the Synthesis of Tumor-Associated T-antigen Mimics.

Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells

Xylosyltransferase Bump-and-hole Engineering to Chemically Manipulate Proteoglycans in Mammalian Cells

Expanding the repertoire of GalNAc analogues for cell-specific bioorthogonal tagging of glycoproteins

Substrate Engagement and Catalytic Mechanisms of N-Acetylglucosaminyltransferase V

Selective bioorthogonal probe for N -glycan hybrid structures

Metabolic Precision Labeling Enables Selective Probing of O-linked N-acetylgalactosamine Glycosylation

Site-Specific Glyco-Tagging of Native Proteins for the Development of Biologicals

Cell-specific bioorthogonal tagging of glycoproteins

A universal glycoenzyme biosynthesis pipeline that enables efficient cell-free remodeling of glycans

Production of Glycopeptide Derivatives for Exploring Substrate Specificity of Human OGA Toward Sugar Moiety

Activity Based High-Throughput Screening for Novel O-GlcNAc Transferase Substrates Using a Dynamic Peptide Microarray

Using High-Throughput Experiments To Screen N -Glycosyltransferases with Altered Specificities

Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe

Enzymatic Synthesis of Novel Terpenoid Glycoside Derivatives Decorated with N-Acetylglucosamine Catalyzed by UGT74AC1

Labeling glycans on living cells by a chemoenzymatic glycoengineering approach

C-Terminal Tag Location Hampers in Vitro Profiling of OGT Peptide Substrates by Mrna Display

Mapping the GALNT1 substrate landscape with versatile proteomics tools

Immobilized enzyme cascade for targeted glycosylation